Lentivirus Production
This guide explains lentivirus production for researchers who need to generate high titer lentiviral particles for gene delivery and stable expression studies. Lentivirus production involves transfecting a packaging cell line with a set of plasmids that encode the viral genome, packaging components, and envelope protein. For foundational molecular biology concepts, refer to the NCBI Bookshelf.
Lentiviral vectors are derived from HIV 1 and offer stable, long term expression in both dividing and non dividing cells. The system requires careful handling under appropriate biosafety precautions. Understanding the viral life cycle and packaging constraints helps avoid common pitfalls, as discussed in the mathematical model of HIV brain infection Global Stability Analysis of HIV Brain Infection.
At a Glance
| Aspect | Key Points |
|---|---|
| Core principle | Transient transfection of HEK293T cells with packaging and transfer plasmids |
| Typical yield | 10^6 to 10^8 transducing units per milliliter after concentration |
| Biosafety level | BSL 2+ for VSV G pseudotyped vectors, consult institutional guidelines |
| Critical decision | Three plasmid vs. four plasmid system, promoter choice, envelope selection |
| Major quality checks | Titer by qPCR or flow cytometry, sterility, endotoxin testing |
| Main risk | Recombination leading to replication competent lentivirus |
Core Concepts and Decision Points
The central decision in lentivirus production is choosing the packaging plasmid system. Most labs use a three plasmid approach: a transfer plasmid containing the gene of interest flanked by long terminal repeats (LTRs), a packaging plasmid encoding gag, pol, rev, and often tat, and an envelope plasmid (usually VSV G). An alternative four plasmid system splits gag pol and rev to further reduce recombination risk. For guidance on vector design and bioinformatics analysis of constructs, consult EMBL EBI Training.
Another key decision is the promoter driving your transgene. Strong constitutive promoters (CMV, EF1a) produce high expression in many cell types, but cell specific promoters may be needed for physiological relevance. The envelope choice affects tropism. VSV G provides broad tropism and stability during concentration, but can cause cytotoxicity at high levels. Inducible envelopes such as RD114 or GaLV are alternatives for sensitive cells.
You must also decide on the production scale. Small scale (10 cm dish) is sufficient for preliminary experiments. Large scale (hyperflask or bioreactor) is needed for in vivo work. The packaging cell line is almost always HEK293T because of high transfection efficiency and the presence of the SV40 large T antigen which amplifies plasmids containing the SV40 origin.
Practical Workflow for Lentivirus Production
The workflow below assumes you have validated plasmids and a certified biosafety cabinet.
1. Plasmid Preparation. Prepare endotoxin free plasmid DNA for all three (or four) plasmids. Use a commercial midiprep or maxiprep kit. Verify the transfer plasmid sequence by Sanger sequencing. For bioinformatics quality control of plasmid maps, use tools from Bioconductor.
2. Cell Culture and Transfection. Seed HEK293T cells the day before transfection so they are 80% to 90% confluent on the day. Culture in DMEM with 10% fetal bovine serum and no antibiotics at 37°C and 5% CO2. Transfect using a calcium phosphate or lipid based reagent. A typical ratio is 3:2:1 (transfer:packaging:envelope) for a three plasmid system. Replace the medium with fresh complete DMEM 6 to 16 hours after transfection.
3. Harvest and Clarification. Collect the supernatant at 48 and 72 hours post transfection. Pool the harvests. Centrifuge at 500 x g for 10 minutes to pellet cell debris, then filter through a 0.45 µm PES filter. Do not use a 0.22 µm filter immediately as it can shear the viral particles, instead use 0.45 µm.
4. Concentration. Concentrate the virus by ultracentrifugation (70,000 to 100,000 x g for 2 hours at 4°C) or using a polyethylene glycol (PEG) precipitation kit. Resuspend the pellet in a small volume of serum free medium or PBS. Aliquot and snap freeze in liquid nitrogen. Store at -80°C.
5. Titration. Determine the functional titer by transducing a target cell line (e.g., HEK293T) with serial dilutions of your virus. Measure transgene expression (e.g., GFP) by flow cytometry after 72 hours. Alternatively, measure physical titer by qPCR for viral RNA or integrated proviral DNA. For standardized titration workflows, see the Galaxy Training Network.
Quality Checks
Every lentivirus preparation must pass several quality control steps.
Titer consistency. Perform at least two independent titrations for each batch. The coefficient of variation should be below 30%. Use a reference virus with a known titer to control for day to day variation.
Sterility and endotoxin. Test a small aliquot on a blood agar plate and in thioglycolate broth for bacterial or fungal growth. Measure endotoxin levels using a LAL assay, levels above 5 EU/mL can cause toxicity in sensitive cells.
Identity and purity. Confirm the transgene sequence by PCR from the viral RNA after reverse transcription. For high throughput sequencing of your virus stock, raw data can be deposited in the NCBI Sequence Read Archive for transparency.
Replication competency. Test for the absence of replication competent lentivirus (RCL) by serial passage of transduced cells and measuring p24 antigen. RCL is a safety risk and must be ruled out before in vivo use.
Common Mistakes
Low titer due to poor transfection. The most frequent problem is low transfection efficiency. Always include a GFP control plasmid in a parallel well to visually confirm >80% positive cells at 24 hours. Use endotoxin free DNA and high quality transfection reagent.
Cytotoxicity from VSV G. Overexpression of VSV G can kill producer cells. Keep the envelope plasmid ratio low (e.g., 1 part envelope to 3 parts transfer plasmid). Harvest earlier if cells show rounding.
Improper storage. Lentivirus loses titer rapidly at 4°C (half life about 2 to 3 days) and after freeze thaw cycles. Always snap freeze single use aliquots and avoid repeated thawing.
Cross contamination of cell lines. Use dedicated hoods and pipettes for virus work. Decontaminate surfaces with 70% ethanol followed by a bleach solution. Monitor for mycoplasma in your HEK293T stock.
Limits and Uncertainty
Lentivirus production is not a fully standardized process and titer estimates have inherent variability. Physical titer (by p24 ELISA) often overestimates functional titer by 10 to 100 fold because many particles are non infectious. Always report functional titer from a transduction assay.
The maximum insert size for a lentiviral transfer plasmid is about 8 to 10 kb. Larger inserts reduce packaging efficiency and titer dramatically. For expression of large genes, consider alternative vector systems.
Not all cell types are transduced equally. Primary neurons and hematopoietic stem cells require higher multiplicity of infection (MOI) and often need spinoculation or addition of polybrene. Even with optimization, some cells remain refractory.
Recombination between plasmids is a theoretical risk. Use minimal homology between components and include a deletion in the packaging plasmid (e.g., deleted env and deleted 3' LTR) to reduce the chance of generating RCL. For a discussion of HIV reactivation dynamics relevant to vector safety, see Regulation of AQP4 by HIV 1 Tat.
Frequently Asked Questions
1. What is the difference between lentivirus and gammaretrovirus? Lentiviruses (e.g., HIV) can infect non dividing cells because their pre integration complex is actively imported into the nucleus. Gammaretroviruses (e.g., MLV) require cell division for integration. Lentivectors are therefore preferred for neurons, macrophages, and other quiescent cells.
2. Can I use lentivirus for in vivo gene delivery? Yes, but vector production must be scaled up (at least 10^9 TU) and purified by ultracentrifugation or chromatography. Expect lower transduction efficiency in tissues due to physical barriers and immune clearance. You must also test for RCL and endotoxin. Refer to your animal ethics committee and institutional biosafety office.
3. How do I increase the titer of my lentivirus? Increase the number of producer cells (e.g., use a 15 cm dish or a cell factory), concentrate the supernatant at least 100 fold, and optimize the transfection ratio. Adding sodium butyrate (10 mM) 24 hours post transfection boosts expression from the CMV promoter but can increase toxicity.
4. How long can I store lentivirus and what is the best buffer? Store at -80°C in small aliquots. The preferred resuspension buffer is PBS with 5% fetal bovine serum or 1% BSA. Avoid freeze thaw cycles. Virus stored for more than 6 months may lose 50% or more of its titer.
References and Further Reading
- NCBI Bookshelf: Molecular Biology of the Cell , foundational cell and viral biology.
- EMBL EBI Training: Bioinformatics for Viral Vectors , design and analysis of vector constructs.
- Galaxy Training Network: Lentivirus Titer Analysis Workflow , reproducible titer calculation from sequencing data.
- Bioconductor: GenomicRanges for Integration Site Analysis , tools for mapping proviral integration.
- NCBI Sequence Read Archive , deposit and share viral vector sequencing data.
- Global Stability Analysis of HIV Brain Infection , mathematical modeling of lentiviral dynamics.
- Regulation of AQP4 by HIV 1 Tat in Astrocytes , study of HIV protein effects relevant to vector design.
- LncRNA MSTRG.16919.1 and BHV 1 Proliferation , example of viral vector use in veterinary research.
- RNF149/RBM25/MYC/PD L1 Axis in ccRCC , application of lentiviral gene knockdown in cancer immunology.
- LOX 1 Silencing in THVECs , lentiviral shRNA delivery for cardiovascular research.